AboutContactsEditorial StaffEditorial CouncilArchiveFor AuthorsFor Reviewers

Relationship Between the Incidence of Chronic Obstructive Pulmonary Diseases and the Prevalence of Tobacco Smoking Among the Population of the Russian Federation

Journal «MEDICINA» 4, 2023, pp.1-9 (Research)


Salagay O. O.
MD, PhD, State Secretary Deputy Minister1

Antonov N. S.
Doctor of Medicine, Leading Researcher2; Head Researcher, Department of Public Health and Demography3

Sakharova G. M.
Doctor of Medicine, Professor, Leading Researcher2; Head Researcher, Department of Public Health and Demography3

Rusakova L. I.
Doctor of Medicine, Head, Scientific and Organizational Department3

1 - Ministry of Health of the Russian Federation, Moscow, Russia
2 - Central Research Institute of Health Organization and Informatization, Ministry of Health of the Russian Federation, Moscow, Russia
3 - Central Research Institute of Tuberculosis, Moscow, Russia

Corresponding Author

Sakharova Galina; e-mail: pulmomail@gmail.com

Conflict of interest

Authors have no conflict of interest.


The study had no sponsorship.


The article analyses morbidity and mortality caused by chronic obstructive pulmonary diseases among the population of the Russian Federation in the period from 2011 to 2019. Two indicators were analyzed in the entire population: the absolute incidence numbers of newly established chronic and unspecified bronchitis, emphysema (J42-J43), and other chronic obstructive pulmonary disease (J44); as well as mortality caused by these diseases, also measured in absolute numbers. To analyze the impact of the prevalence of tobacco smoking among the population on morbidity and mortality, the observation period was split into two time periods: 2011-2014 before the adoption of Federal Law No. 15-FZ «On protecting the health of citizens from the effects of second-hand tobacco smoke, the consequences of tobacco consumption or the consequences of the consumption of nicotine-containing products», 2014-2019 after the adoption of the law. Linear approximation was used to assess the dynamics of changes in the indicators, the dynamic trends of the indicators were built for the selected time periods. The results of the study showed that morbidity and mortality from chronic obstructive pulmonary diseases after the adoption of Federal Law No. 15-FZ, resulting in the constant annual decrease in the prevalence of smoking in the Russian Federation, reversed from a steady increase to a steady decrease. However, the beginning of the decrease in mortality was observed later (2015) than the decrease of incidence (2014), and the rate of decrease in mortality was 2 times lower than the rate of decrease in incidence.

Key words

tobacco smoking prevalence, chronic obstructive pulmonary diseases, COPD incidence, COPD mortality, chronic bronchitis incidence, anti-tobacco law



1. Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease, Updated 2023. Available at: http://www.goldcopd.com/

2. Lopez A.D., Shibuya K., Rao C., et al. Chronic obstructive pulmonary disease: current burden and future projections. Eur Respir J. 2006; 27: 397-412.

3. Tackling NCDs. Best buys and other recommended interventions for the prevention and control of noncommunicable diseases. Geneva, World Health Organization, 2017. Available at: http://apps.who.int/iris/bitstream/ 10665/259232/1/WHO-NMHNVI-17.9-eng.pdf. Accessed: 17.01.2020.

4. Kim W., Prokopenko D., Sakornsakolpat P., et al. Genome-wide gene-by-smoking interaction study of chronic obstructive pulmonary disease. Am J Epidemiol 2021; 190: 875-85.

5. Salagaj O.O., Antonov N.S., Saharova G.M., Peredel'skaya M.Yu., Starodubov V.I. Vliyanie tabakokureniya na razvitie i techenie hronicheskogo bronhita. [The influence of tobacco smoking on the development and course of chronic bronchitis.] Profilakticheskaya medicina [The Russian Journal of Preventive Medicine] 2020; 23(4): 7-13, doi: 10.17116/profmed2020230417 (In Russ.)

6. Yang I.A., Jenkins C.R., Salvi S.S. Chronic obstructive pulmonary disease in never-smokers: risk factors, pathogenesis, and implications for prevention and treatment. Lancet Respir Med 2022; 10(5): 497-511, doi: 10.1016/S2213-2600(21)00506-3

7. Lange P., Celli B., Agusti A., et al. Lung-function trajectories leading to chronic obstructive pulmonary disease. N Engl J Med 2015; 373: 111-122.

8. Agusti A., Faner R. Lung function trajectories in health and disease. Lancet Respir Med 2019; 7: 358-364.

9. Boyce W.T., Levitt P., Martinez F.D., McEwen B.S., Shonkoff J.P. Genes, environments, and time: the biology of adversity and resilience. Pediatrics 2021; 147: e20201651.

10. Fletcher C., Peto R. The natural history of chronic airflow obstruction. BMJ 1977; 1: 1645-1648, doi: 10.1136/bmj.1.6077.1645

11. Saharova G.M., Antonov N.S., Salagaj O.O. Monitoring rasprostranennosti potrebleniya tabaka v Rossijskoj Federacii: Global'nyj opros vzroslogo naseleniya v 2009 i 2016. [Monitoring the prevalence of tobacco consumption in the Russian Federation: Global Adult Tobacco Surveys in 2009 and 2016.] Medicina [Medicine] 2017; (2): 64-72. (In Russ.)

12. Salagaj O.O., Saharova G.M., Antonov N.S., Nikitina S.Yu., Stadnik N.M., Starodubov V.I. Ocenka rasprostranennosti povedencheskih faktorov riska i ih vliyaniya na zdorov'e vzroslogo naseleniya v Rossijskoj Federacii. [Assessment of the prevalence of behavioral risk factors and their impact on the health of the adult population in the Russian Federation] Voprosy statistiki [Statistics questions] 2023; 30(2): 72-86, doi: 10.34023/2313-6383-2023-30-2-72-86 (In Russ.)

13. Lim S.S., Vos T., Flaxman A.D., et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 19902010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012; 380: 2224-2260.

14. Godtfredsen N.S., Lam T.H., Hansel T.T., Leon M.E., Gray N., Dresler C., Burns D.M., Prescott E., Vestbo J., COPD-related morbidity and mortality after smoking cessation: status of the evidence. Eur Respir J 2008; 32: 844-853, doi: 10.1183/09031936.00160007

15. Burney P., Jithoo A., Kato B., et al. Chronic obstructive pulmonary disease mortality and prevalence: the associations with smoking and poverty a BOLD analysis. Thorax 2014; 69: 465-473, doi: 10.1136/thoraxjnl-2013-204460